These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9767844)

  • 1. [Cervical-vaginal smears: an unpopular test!].
    Gompel C
    Presse Med; 1998 Jun; 27(20):971-3. PubMed ID: 9767844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory closure of cervical cytology laboratories: recommendations for a public health response.
    MMWR Recomm Rep; 1997 Dec; 46(RR-17):1-19. PubMed ID: 9409538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
    Budge M; Halford J; Haran M; Mein J; Wright G
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Pap smear quality-assurance system in family practice.
    Curtis P; Varenholt JJ; Skinner B; Addison L; Resnick J; Kebede M
    Fam Med; 1993 Feb; 25(2):135-9. PubMed ID: 8458544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro conventional cytology historical strengths and current limitations.
    Spitzer M
    Obstet Gynecol Clin North Am; 2002 Dec; 29(4):673-83. PubMed ID: 12509091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a zero error standard exist for the Papanicolaou smear? A pathologist's perspective.
    Frable WJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):301-10. PubMed ID: 9111124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
    Sirovich BE; Gottlieb DJ; Fisher ES
    J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
    Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening: the Pap smear. Summary of an NIH consensus statement.
    Br Med J; 1980 Nov; 281(6250):1264-6. PubMed ID: 7427661
    [No Abstract]   [Full Text] [Related]  

  • 11. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
    Ferris DG; Payne P; Frisch LE; Milner FH; diPaola FM; Petry LJ
    J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
    Eltabbakh GH; Eltabbakh GD
    J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case study of the effectiveness of nurse-led screening programmes for cervical cancer among Hong Kong Chinese women.
    Twinn S; Cheng F
    J Adv Nurs; 1999 May; 29(5):1089-96. PubMed ID: 10320491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of cervical cancer: screening, progress and perspectives].
    Monsonego J
    Presse Med; 2007 Jan; 36(1 Pt 2):92-111. PubMed ID: 17296477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
    Linder J; Zahniser D
    Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current status of the Papanicolaou smear.
    Shingleton HM; Patrick RL; Johnston WW; Smith RA
    CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors related to poor practice of Pap smear screening among secondary school teachers in Malaysia.
    Abdullah F; Aziz NA; Su TT
    Asian Pac J Cancer Prev; 2011; 12(5):1347-52. PubMed ID: 21875295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.